GTF3C5
Basic information
Region (hg38): 9:133030675-133058503
Links
Phenotypes
GenCC
Source:
- complex neurodevelopmental disorder (Limited), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GTF3C5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 50 | 53 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 51 | 4 | 0 |
Variants in GTF3C5
This is a list of pathogenic ClinVar variants found in the GTF3C5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-133031024-G-A | not specified | Uncertain significance (Nov 09, 2024) | ||
9-133031030-G-T | not specified | Uncertain significance (Dec 02, 2022) | ||
9-133031031-A-G | not specified | Uncertain significance (Jan 08, 2024) | ||
9-133031032-T-G | not specified | Uncertain significance (Jan 21, 2025) | ||
9-133031048-G-A | not specified | Uncertain significance (Aug 20, 2024) | ||
9-133031049-C-T | not specified | Uncertain significance (Mar 18, 2024) | ||
9-133031051-G-A | not specified | Likely benign (Jun 06, 2023) | ||
9-133031069-C-T | not specified | Uncertain significance (Apr 22, 2022) | ||
9-133031081-A-G | not specified | Uncertain significance (Feb 13, 2025) | ||
9-133031108-G-A | not specified | Uncertain significance (Feb 11, 2025) | ||
9-133031126-A-G | not specified | Uncertain significance (Jun 16, 2023) | ||
9-133031129-C-G | not specified | Uncertain significance (Jan 16, 2025) | ||
9-133031156-G-A | not specified | Uncertain significance (Aug 23, 2021) | ||
9-133042108-A-G | not specified | Uncertain significance (Jun 05, 2023) | ||
9-133042141-T-C | not specified | Uncertain significance (Feb 25, 2025) | ||
9-133042165-C-T | not specified | Uncertain significance (Mar 22, 2022) | ||
9-133042192-C-T | not specified | Uncertain significance (Jun 11, 2021) | ||
9-133042193-G-T | not specified | Uncertain significance (Jan 27, 2022) | ||
9-133042223-G-T | not specified | Uncertain significance (Apr 12, 2023) | ||
9-133042292-T-A | not specified | Uncertain significance (Jan 26, 2025) | ||
9-133043728-G-C | not specified | Uncertain significance (Dec 17, 2024) | ||
9-133043762-G-A | not specified | Likely benign (Mar 20, 2024) | ||
9-133043772-G-A | not specified | Uncertain significance (Aug 10, 2021) | ||
9-133043812-G-A | not specified | Uncertain significance (Nov 23, 2022) | ||
9-133043817-G-T | Multisystem developmental disorder | Uncertain significance (Feb 02, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GTF3C5 | protein_coding | protein_coding | ENST00000372108 | 12 | 27815 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.62e-8 | 0.958 | 125677 | 0 | 71 | 125748 | 0.000282 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.772 | 292 | 332 | 0.881 | 0.0000207 | 3418 |
Missense in Polyphen | 78 | 108.23 | 0.7207 | 1053 | ||
Synonymous | -0.999 | 149 | 134 | 1.11 | 0.00000872 | 1014 |
Loss of Function | 2.02 | 17 | 28.7 | 0.593 | 0.00000162 | 308 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000698 | 0.000696 |
Ashkenazi Jewish | 0.000908 | 0.000893 |
East Asian | 0.000438 | 0.000435 |
Finnish | 0.000185 | 0.000185 |
European (Non-Finnish) | 0.000221 | 0.000220 |
Middle Eastern | 0.000438 | 0.000435 |
South Asian | 0.0000989 | 0.0000980 |
Other | 0.000655 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in RNA polymerase III-mediated transcription. Integral, tightly associated component of the DNA-binding TFIIIC2 subcomplex that directly binds tRNA and virus-associated RNA promoters.;
- Pathway
- Gene expression (Transcription);rna polymerase iii transcription;RNA Polymerase III Abortive And Retractive Initiation;RNA Polymerase III Transcription Initiation From Type 1 Promoter;RNA Polymerase III Transcription Initiation From Type 2 Promoter;RNA Polymerase III Transcription Initiation;RNA Polymerase III Transcription
(Consensus)
Recessive Scores
- pRec
- 0.109
Intolerance Scores
- loftool
- 0.744
- rvis_EVS
- -1.11
- rvis_percentile_EVS
- 6.83
Haploinsufficiency Scores
- pHI
- 0.126
- hipred
- Y
- hipred_score
- 0.746
- ghis
- 0.614
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.869
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gtf3c5
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- transcription by RNA polymerase III;skeletal muscle cell differentiation;5S class rRNA transcription by RNA polymerase III;tRNA transcription by RNA polymerase III;RNA polymerase III preinitiation complex assembly
- Cellular component
- transcription factor TFIIIC complex;nucleoplasm
- Molecular function
- RNA polymerase III general transcription initiation factor activity;RNA polymerase III type 1 promoter sequence-specific DNA binding;RNA polymerase III type 2 promoter sequence-specific DNA binding;RNA polymerase III transcription regulator recruiting activity;DNA binding;protein binding